期刊
CIRCULATION
卷 139, 期 12, 页码 E553-E578出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIR.0000000000000598
关键词
AHA Scientific Statements; antibodies; heart transplantation; human leukocyte antigen
Sensitization, defined as the presence of circulating antibodies, presents challenges for heart transplant recipients and physicians. When present, sensitization can limit a transplantation candidate's access to organs, prolong wait time, and, in some cases, exclude the candidate from heart transplantation altogether. The management of sensitization is not yet standardized, and current therapies have not yielded consistent results. Although current strategies involve antibody suppression and removal with intravenous immunoglobulin, plasmapheresis, and antibody therapy, newer strategies with more specific targets are being investigated.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据